UIM2:XETRA:XETRA-UBS(Lux)Fund Solutions – Factor MSCI EMU Quality UCITS ETF(EUR)A-dis (EUR)

ETF | Others |

Last Closing

USD 26.89

Change

+0.07 (+0.26)%

Market Cap

N/A

Volume

265.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.15 (-0.33%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.40 (-0.41%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.08 (-0.32%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.07 (-0.53%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.02 (-0.37%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.12 (-0.52%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.08 (-0.60%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.62 (+1.16%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.02 (-0.21%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.03 (+0.02%)

USD 12.26B

ETFs Containing UIM2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.71% 77% C+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.71% 78% C+ 71% C-
Trailing 12 Months  
Capital Gain -0.39% 19% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.39% 21% F 25% F
Trailing 5 Years  
Capital Gain 80.54% 53% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 80.54% 54% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain 8.71% 57% F 58% F
Dividend Return 9.83% 61% D- 60% D-
Total Return 1.13% 73% C 52% F
Risk Return Profile  
Volatility (Standard Deviation) 17.15% 27% F 40% F
Risk Adjusted Return 57.35% 48% F 54% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.